In a year, Supernal laid off nearly 400 workers while it paused aircraft programs in order to evaluate next steps.

The Critical Design Review of the CERP program paves the way for the modification of two B-52 bombers with the new engines, ...

The new trend of "vibe coding" allows people to program software without writing a single line of code. Now, a new study by ...

Foundational alliance supports phased migration and hybrid architecture approaches for enterprises managing mainframe-dependent infrastructure TOKYO, April 28, 2026 /PRNewswire/ -- OpenLegacy Japan Co ...

Several educational and developer platforms have published updated Java project collections, many with source code, to help learners practice and apply programming concepts. These collections include ...

Java remains one of the most in-demand programming languages, making interview preparation a must for aspiring developers. From mastering OOP and modern Java features to refining interview presence, ...

Northrop Grumman (NOC) and the U.S. Air Force on Monday reported continued progress on the LGM-35A Sentinel intercontinental ballistic missile program, with development milestones achieved across ...

Abstract: Many organizations rely on software systems to perform their core business operations. These systems often require modernization to accommodate new requirements and demands over time. Visual ...

Sonogenetics, discovered by SonoNeu founder Sreekanth Chalasani, is a new modality using ultrasound to precisely control specific cells ‘tagged’ with special proteins SonoNeu is part of a ...

SAN DIEGO, CA / ACCESS Newswire / April 7, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), pioneering novel solutions for severe pain with built-in abuse and overdose ...

The State of Texas has opened applications for $350 million in advanced nuclear grants through the Texas Advanced Nuclear Development Fund (TANDF), making the nation’s largest state‑level nuclear ...

Tivic Health Systems, Inc. is a biotechnology company developing immunotherapeutic approaches to modulating immune responses. In the past year, the company has shifted its focus to drug development ...